Assessment - web

Information Collections to Advance State, Tribal, Local and Territorial (STLT) Governmental Agency System Performance, Capacity, and Program Delivery

AttB_Survey_WebVersion

Assessment of STLT Public Health Agencies to Guide the Update of CDC/ATSDR Cancer Cluster Guidelines

OMB: 0920-0879

Document [pdf]
Download: pdf | pdf
Confidential

Page 1

2019 STLT Public Health Agency Cancer Cluster Response

Form Approved
OMB No. 0920-0879
Exp. Date 01/31/2021
The Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry
(ATSDR) are updating “Investigating Suspected Cancer Clusters and Responding to Community Concerns: Guidelines
from CDC and the Council of State and Territorial Epidemiologist” (hereafter referred to as the 2013 CDC/CSTE
Guidelines; https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6208a1.htm). To help inform the update, CDC/ATSDR is
gathering input from subject matter experts and stakeholders, including state, tribal, local, and territorial (STLT)
public health agencies.
We recognize that STLT public health agencies use different terms when describing “suspected cancer clusters.” For
the purposes of this survey, the term “inquiries about excess cancer” refers to inquiries about excess or elevated
cancer cases in a particular geographic area possibly linked with an environmental hazard (this includes, but is not
limited to, suspected cancer clusters). The goal of this survey is to gather input from STLT public health agencies
about how they address community concerns about excess cancer, available and needed resources, and barriers,
facilitators, and best practices for effectively responding to community concerns.
The survey, which may take approximately 30 minutes to complete, is intended to be completed by an individual
who is familiar with the agency’s process for responding to inquiries about excess cancer. Participation is voluntary
and responses to all questions will be kept secure to the fullest extent allowed by law. Aggregate information
gathered from this survey may be included in the updated Guidelines document and/or published separately.
CDC/ATSDR will only release information in aggregate form and will ensure that no individual or public health agency
is identifiable.
Thank you in advance for your participation. We kindly request that you complete this assessment by INSERT DATE.
If you have any questions or would like to provide additional input into the Guidelines update, please contact us at
[email protected]
CDC estimates the average public reporting burden for this collection of information as 30 minutes per response,
including the time for reviewing instructions, searching existing data/information sources, gathering and maintaining
the data/information needed, and completing and reviewing the collection of information. An agency may not
conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a
currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this
collection of information, including suggestions for reducing this burden, to: CDC/ATSDR Information Collection
Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0879)

06/26/2020 9:22am

projectredcap.org

Confidential
Page 2

Agency Information
1

Which type of jurisdiction is your public health agency affiliated with?
Federal
State
Territory
City or County (Local)
Tribe or Tribal Epidemiology Center
Other
If other, please type in type of jurisdiction

__________________________________
2

What is the name of your agency? (do not abbreviate)

__________________________________
3

What is your title? (do not abbreviate)

__________________________________
4

What is your role within the agency as it relates to addressing inquiries about excess cancer?
Epidemiologist
Environmental health specialist/toxicologist
Cancer registry staff
Statistician
Communications staff
Other
Don't Know
If other, please specify what role is

__________________________________
5

Is your public health agency responsible for responding to inquiries about excess cancer?
Yes, my agency responds to inquires when they are received
No, my agency refers inquiries to another agency or organization (e.g., state health department)
Don't know
What agency or organization do you refer inquiries to?
__________________________________

06/26/2020 9:22am

projectredcap.org

Confidential
Page 3

Is there someone else in your agency who would be better suited to complete this survey?
Yes. If so please, forward this to the appropriate individual.
No
6

Over the past 7 years, has your public health agency recieved one or more inquiries about excess cancer?
Yes
No
Don't Know

7

About how many inquiries about excess cancer does your public health agency receive each year?
1-5
6-10
11-25
>26
Don't Know

06/26/2020 9:22am

projectredcap.org

Confidential
Page 4

Guidleines and Protocols
8

Is your public health agency familiar with the 2013 CDC/CSTE Guidelines for "Investigating Suspected Cancer
Clusters and Responding to Community Concerns"?
Very familiar with the Guidelines
Somewhat familiar with the Guidelines
Have heard of the Guidelines, but have not read them
Have NOT heard of the Guidelines
Don't Know

9

Please rate the usefulness of the 2013 CDC/CSTE Guidelines
Extremely useful
Very useful
Moderately useful
Slightly useful
Not at all useful
Don't know

10

Does your public health agency have a written protocol for addressing inquiries about excess cancer?
Yes
No
Don't Know

11

If you are willing to share a copy of your agency's protocol with CDC, please upload here.

12

Is your public health agency's protocol consistent with the 2013 CDC/CSTE Guidelines?
Yes, our agency uses the 2013 Guidelines without modification
Yes, our agency protocol is consistent with the 2013 Guidelines with some modification
No, our agency protocol is not consistent with the 2013 CDC/CSTE Guidelines
Don't Know

13

Does your public health agency use the term “cluster” when addressing community concerns about elevated cancer
rates in a specific geographic area?
Yes
No
Don't Know

14

What term(s) does your agency use?

__________________________________
15

The 2013 CDC/CSTE Guidelines define a cancer cluster as “a greater than expected number of cancer cases that
occurs within a group of people in a geographic area over a defined period of time.”
Do you think this definition of a cancer cluster should be revised in the updated guidelines?
Yes, the definition should be revised
No, the definition should remain the same
Don't Know, I'm not familiar with the cancer cluster definition

16

How should the definition of cancer clusters be revised?

06/26/2020 9:22am

projectredcap.org

Confidential
Page 5

17

The 2013 CDC/CSTE Guidelines recommend a four-step approach to addressing cancer cluster inquiries.
Should the four-step approach be revised in the updated guidelines?
Yes, the four-step approach should be revised
No, the four-step approach should remain the same
Neutral
Don't Know, I'm not familiar with the approach in the Guidelines

18

How should the approach be revised?

19

How helpful would it be to your public health agency if CDC/ATSDR broadened the scope of the updated guidelines to
more broadly address community concerns about “cancer and environmental hazards” rather than focusing on
“suspected cancer clusters”?
Very helpful
Somewhat helpful
Not helpful
Don't Know

06/26/2020 9:22am

projectredcap.org

Confidential
Page 6

Public Health Agency Response Activities
20

Does your public health agency have a tracking system in place to record or log inquiries about excess cancer?
Yes
No
Don't Know

21

How many inquiries about excess cancer did your public health agency receive in 2019?
(Please use data from your agency’s tracking system, if one exists. Otherwise, please estimate the number of
inquiries received.)

__________________________________
(Please indicate if not known or if not tracked and unable to estimate)
22

The number provided above is:
Actual/measure
Estimated

23

When considering all the inquiries your agency received in 2019, please select the source(s) of these inquiries.
(Check all that apply)
Individual Resident
Community or Advocacy Group
Physician/Health Care Provider
Local Health Department
State Cancer Registry
Other State Agency
Federal Agency
Elected Official
News Media
Other
Individual Resident: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Community or Advocacy Group: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Physician/Health Care Provider: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Local Health Department: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
06/26/2020 9:22am

projectredcap.org

Confidential
Page 7

State Cancer Registry: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Other State Agency: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Federal Agency: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Elected Official: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
News Media: Number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)
Other: Name source(s) and provide number of inquiries?

__________________________________
(Please note that the total numbers for all sources checked should add up to the response provided in Question 21)

06/26/2020 9:22am

projectredcap.org

Confidential
Page 8

24. When considering all the inquiries your agency received in 2019, please tell us how often
did your agency carry out the following activities.
Never or
Almost Never
(>10%)

Rarely
(10-40%)

Sometimes
(40-60%)

Often
(60-90%)

Always or
Not Applicable
Almost Always
(90-100%)

Respond to email/phone inquiry
Provide education during initial
email/phone contact
Contact state health department
(if applicable)
Analyze cancer registry data to
determine whether there is an
elevated rate of cancer in the
community of concern (e.g.,
calculate an SIR)
Collect additional information
about cases, such as potential
exposures and risk factors (e.g.,
conduct case series study or
case reports)
Conduct a case-control study
Review environmental data
Conduct environmental sampling
Contact federal agency for
technical assistance
Contact non-governmental
organization, (e.g. academia,
local medical community,
clinician, Pediatric
Environmental Health Specialty
Units/PEHSU) for assistance
Create public communication
product (e.g. web, printed
materials, social media)
Release information through
news media
Hold community meeting(s)
Establish a Community Advisory
Panel
Prepare written report for public
dissemination

If any, please list other activities not listed above that your agency may conduct:
(Additionally please indicate how often each activity is conducted using the scale in the previous question)

06/26/2020 9:22am

projectredcap.org

Confidential
Page 9

25

Does your agency routinely conduct follow-up activities on previous inquiries (e.g., follow-up communication,
recalculate cancer statistics on a recurring basis, etc.)?
Yes
No
Don't Know

26

In 2019, how many inquiries from previous years did your agency conduct follow-up activities for?

__________________________________
(Indicate if not known, or not tracked)
27

To more fully understand your agency’s approach, CDC/ATSDR would like to review example reports or documents
that highlight how your agency responds to inquiries about excess cancer. If you are willing to share any documents,
please upload.

28

Does your public health agency use geospatial software and methods when addressing inquiries about excess cancer
(for example, to assess whether there is an elevated number of cancer cases in a particular location and time)?
Yes
No
Don't Know

29

If no, why not?
Geospatial methods are not part of the 2013 CDC/CSTE Guidelines
Do not have trained staff
Software too expensive
Do not receive many inquiries
Other
If other, please write in here.

30

__________________________________

Does your public health agency analyze cancer incidence data on a routine basis to proactively look for geographic
areas with elevated cancer rates?
Yes
No
Don't Know

31

Does your jurisdiction have a CDC-funded Environmental Public Health Tracking program? For more information see:
http://ephtracking.cdc.gov/showHome.action
Yes
No
Don't know

06/26/2020 9:22am

projectredcap.org

Confidential
Page 10

32

Does the program/team that responds to inquiries about excess cancer (and conducts investigations into excess
cancer) coordinate with the CDC-funded Environmental Public Health Tracking program?
Yes, they are part of the same program
Yes, the programs coordinate but they are separate programs
No
Don't know

33

How does the Environmental Public Health Tracking program contribute to your agency's ability to respond to
inquiries about excess cancer?
(If a tracking program exists but does not contribute to this work, please indicate so in box)

34

Does your jurisdiction have an ATSDR-funded APPLETREE (ATSDR’s Partnership to Promote Localized Efforts to
Reduce Environmental Exposure) program? For more information see: https://www.atsdr.cdc.gov/states/index.html
Yes
No
Don't Know

35

Does the program/team that responds to inquiries about excess cancer (and conducts investigations into excess
cancer) coordinate with the ATSDR-funded APPLETREE program?
Yes, they are part of the same program
Yes, the programs coordinate but they are separate programs
No
Don't Know

36

How does the APPLETREE program contribute to your agency’s ability to respond to inquiries about excess cancer?
(if program exists, but does not contribute please indicate so in box)

06/26/2020 9:22am

projectredcap.org

Confidential
Page 11

Communication with the Public
37

Does your public health agency have a written protocol for how to communicate with the public regarding potential
cancer clusters?
Yes, as a separate document specific to cancer cluster communications
Yes, as part of the agency's protocol for addressing inquiries about excess cancer
No
Don't know

38

If you are willing to share a copy of your agency's protocol with CDC, please upload here.

(This refers to the protocol in Question 37)
39

Is your public health agency familiar with the Cancer Cluster Communication Toolkit developed by CDC and the
National Public Health Information Center? (available at: https://www.nphic.org/toolkits/cancer-cluster)
Very familiar with the Communications Toolkit
Somewhat familiar with the Communications Toolkit
Have heard of the Communications Toolkit, but have not read it (or am not familiar with it)
Have NOT heard of the Communications Toolkit
Don't know

40

Please rate the usefulness of the Communications Toolkit.
Extremely useful
Very useful
Moderately useful
Slightly useful
Not at all useful
Don't know

41

CDC/ATSDR is interested in receiving input on the current and updated guidelines from community members and
advocacy groups. Please provide the name of individuals or advocacy groups that you believe might be helpful in
obtaining such input.
(If none, please respond N/A)

06/26/2020 9:22am

projectredcap.org

Confidential
Page 12

Personnel
42

Approximately how many people in your public health agency are involved in responding to inquiries about excess
cancer on a routine basis? (Number of people)

__________________________________
(If not known, please write in "Don't Know")
43

For each person involved in responding to inquiries about excess cancer, please provide the following information:
Estimates percent time spent addressing these inquires in the past year (note that 100% is equal to 40 hrs/wk) Job
Title or Discipline (e.g., Epidemiologist, Health Communicator, Statistician, Environmental Health Scientist, GIS
analyst) Agency/Department/Organization (e.g., Health Department, Cancer Registry, Environmental Protection)
(Provide information for EACH person. Example: Individual 1, Individual 2, etc.)

44

Does your public health agency have health communicators trained specifically on how to address inquiries about
excess cancer?
Yes
No
Don't Know

45

Does your public health agency have personnel trained in geospatial analysis who are available to assist with
addressing inquiries about excess cancer?
Yes
No
Don't Know

06/26/2020 9:22am

projectredcap.org

Confidential
Page 13

Barriers, Facilitators, and Needed Resources
46

What are the top 3 barriers (i.e., factors that limit or restrict) for effectively addressing inquiries about excess
cancer?
(If not known, please write in "Don't Know")

47

What are the top 3 facilitators (i.e., factors that promote or help) for effectively addressing inquiries about excess
cancer?
(If not known, please write in "Don't Know")

48

What communication resources would improve your agency’s ability to effectively address inquiries about excess
cancer?
(If not known, please write in "Don't Know")

49

What scientific or technical resources would improve your agency’s ability to effectively address inquiries about
excess cancer?
(If not known, please write in "Don't Know")

50

What type of Federal governmental assistance would your public health agency find most useful?
(If not known, please write in "Don't Know")

06/26/2020 9:22am

projectredcap.org

Confidential
Page 14

Best Practices and Recommendations for Updated Guidelines
51

Has your public health agency ever formally evaluated any aspect (e.g., risk communication and education) of your
agency’s approach to addressing inquiries about excess cancer?
Yes
No
Don't Know

52

If you are willing to share the finding of your evaluation, please upload here.

53

What are best practices for communicating with the public about inquiries about excess cancer?
(If not known, please write in "Don't Know")

54

What are best practices for assessing and investigating inquiries about excess cancer?
(If not known, please write in "Don't Know")

55

Please use this space to provide any additional information or comments you would like to share with CDC/ATSDR.

06/26/2020 9:22am

projectredcap.org


File Typeapplication/pdf
File Modified2020-06-26
File Created2020-06-26

© 2024 OMB.report | Privacy Policy